Form 4 for DXCM Dexcom
Accepted 2022-05-23 00:00:00 ET · period of report 2022-05-20 · accession 0001093557-22-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-23 | 2022-05-19 | DXCM | Collins Richard Alexander | Dir | J - Other | $0.00 | -910 | 0 | -100% | $0 | |
| I | 2022-05-23 | 2022-05-19 | DXCM | Collins Richard Alexander | Dir | J - Other | $0.00 | +910 | 8,114 | +13% | $0 |
| 2022-05-23 | 2022-05-20 | DXCM | Collins Richard Alexander | Dir | A - Grant | $0.00 | +987 | 987 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-19 | J | D | 910 | $0.00 | 0 | D by Trust | — | — | (F1) Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. |
| 2 | Common | Common Stock | 2022-05-19 | J | A | 910 | $0.00 | 8,114 | I | — | — | (F1) Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. (F4) Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. |
| 3 | Common | Common Stock | 2022-05-20 | A | A | 987 | $0.00 | 987 | D | — | — | (F2) The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. (F3) Represents 987 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. |